Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Terpos

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Journal of Medical Economics|February 6, 2016
Cost of skeletal complications from bone metastases in six European countriesJ Pereira, J-J Body, O Gunther, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 2008
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acidM A Dimopoulos, E Kastritis, C Bamia, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 15, 2012
High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral densityE Voskaridou, D Christoulas, E Plata, et al.
Leukemia|August 27, 2010
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapiesM A Dimopoulos, E Kastritis, D Christoulas, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromesJ Meletis, E Terpos, M Samarkos, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 12, 2009
The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of boneS A Polyzos, A D Anastasilakis, Z Efstathiadou, et al.
Haematologia|May 10, 2001
Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disordersJ Meletis, E Terpos, M Samarkos, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2016
Fetal Erythropoiesis after Allogeneic Bone Marrow Transplantation Estimated by the Peripheral Blood Erythrocytes Containing Hemoglobin F (F-cells)J Meletis, M Dalekou, M Samarkos, et al.
Leukemia|September 19, 2013
VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCTE Terpos, D Christoulas, E Kastritis, et al.
Journal of Surgical Oncology|October 31, 2009
Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancerC S Boskos, C Liacos, D Korkolis, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Journal of Medical Economics|February 6, 2016
Cost of skeletal complications from bone metastases in six European countriesJ Pereira, J-J Body, O Gunther, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 2008
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acidM A Dimopoulos, E Kastritis, C Bamia, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 15, 2012
High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral densityE Voskaridou, D Christoulas, E Plata, et al.
Leukemia|August 27, 2010
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapiesM A Dimopoulos, E Kastritis, D Christoulas, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromesJ Meletis, E Terpos, M Samarkos, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 12, 2009
The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of boneS A Polyzos, A D Anastasilakis, Z Efstathiadou, et al.
Haematologia|May 10, 2001
Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disordersJ Meletis, E Terpos, M Samarkos, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2016
Fetal Erythropoiesis after Allogeneic Bone Marrow Transplantation Estimated by the Peripheral Blood Erythrocytes Containing Hemoglobin F (F-cells)J Meletis, M Dalekou, M Samarkos, et al.
Leukemia|September 19, 2013
VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCTE Terpos, D Christoulas, E Kastritis, et al.
Journal of Surgical Oncology|October 31, 2009
Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancerC S Boskos, C Liacos, D Korkolis, et al.
Pageof 11